We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+8.57%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$3.62B
AUM Growth
+$248M
(+7.3%)
Cap. Flow
+$9.74M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
28.3%
Holding
840
New
137
Increased
216
Reduced
252
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 Value ETF
IWN
|
+$69.6M |
| 2 |
iShares California Muni Bond ETF
CMF
|
+$29.8M |
| 3 |
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
|
+$12.4M |
| 4 |
TSMC
TSM
|
+$11.8M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$7.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$64.5M |
| 2 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$30M |
| 3 |
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
|
+$8.08M |
| 4 |
IBTE
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
|
+$7.33M |
| 5 |
CVS Health
CVS
|
+$7.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.11% |
| 2 | Healthcare | 8.25% |
| 3 | Financials | 6.95% |
| 4 | Communication Services | 4.77% |
| 5 | Consumer Discretionary | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
701
DELISTED
Inozyme Pharma
INZY
| $186K | 0.01% |
+24,300
| New | +$133K |
|
702
Liquidity Services
LQDT
$1.17B
| $186K | 0.01% |
+10,000
| New | +$174K |
|
703
Viatris
VTRS
$20.1B
| $185K | 0.01% |
15,530
+210
| +1% | +$2.53K |
|
|
PETQ
704
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $183K | 0.01% |
+10,000
| New | +$178K |
|
705
Tenaya Therapeutics
TNYA
$168M
| $172K | ﹤0.01% |
32,900
| – | – |
|
706
GoodRx Holdings
GDRX
$1B
| $165K | ﹤0.01% |
+23,200
| New | +$153K |
|
707
Caesarstone
CSTE
$72.3M
| $162K | ﹤0.01% |
+39,555
| New | +$162K |
|
708
Alight
ALIT
$497M
| $162K | ﹤0.01% |
820
-730
| -47% | -$132K |
|
709
Community Health Systems
CYH
$385M
| $159K | ﹤0.01% |
+45,400
| New | +$153K |
|
710
Laureate Education
LAUR
$5.18B
| $152K | ﹤0.01% |
10,400
| – | – |
|
711
Future Fuel
FF
$204M
| $151K | ﹤0.01% |
+18,800
| New | +$115K |
|
712
SiriusPoint
SPNT
$2.98B
| $150K | ﹤0.01% |
+11,800
| New | +$141K |
|
713
Hamilton Insurance Group
HG
$3.59B
| $145K | ﹤0.01% |
+10,400
| New | +$151K |
|
714
Trevi Therapeutics
TRVI
$2.49B
| $141K | ﹤0.01% |
+40,900
| New | +$91.3K |
|
715
LXP Industrial Trust
LXP
$3.53B
| $140K | ﹤0.01% |
3,109
-4,080
| -57% | -$185K |
|
716
Voyager Therapeutics
VYGR
$187M
| $128K | ﹤0.01% |
+13,700
| New | +$116K |
|
717
IonQ
IONQ
$12.3B
| $126K | ﹤0.01% |
12,600
| – | – |
|
718
SIGA Technologies
SIGA
$223M
| $122K | ﹤0.01% |
+14,300
| New | +$81.6K |
|
|
HOUS
719
DELISTED
Anywhere Real Estate
HOUS
| $118K | ﹤0.01% |
+19,100
| New | +$126K |
|
720
Organogenesis Holdings
ORGO
$308M
| $115K | ﹤0.01% |
40,400
+4,500
| +13% | +$15.3K |
|
|
SGMA
721
DELISTED
Sigmatron International
SGMA
| $113K | ﹤0.01% |
31,154
+9,879
| +46% | +$33.2K |
|
|
LONA
722
LeonaBio Inc
LONA
$69.4M
| $111K | ﹤0.01% |
+4,047
| New | +$128K |
|
723
Lifetime Brands
LCUT
$199M
| $110K | ﹤0.01% |
+10,500
| New | +$92.4K |
|
724
Spero Therapeutics
SPRO
$68.9M
| $105K | ﹤0.01% |
+60,900
| New | +$95.5K |
|
|
NHS
725
Neuberger High Yield Strategies Fund Inc
NHS
$252M
| $87.4K | ﹤0.01% |
10,839
| – | – |
|
Similar funds
EC
SFM
NHC
EQF
NEI
MYIA
Bailard's Q1 2024 Portfolio in Review
As of Q1 2024, Bailard held 840 positions worth $3.62B, up 7.3% from $3.38B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bailard's Q1 2024 filing shows 137 new, 216 increased, 252 reduced and 109 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 82,419 shares worth $7.8M. The largest sale was SPDR Gold Trust, an estimated $64.5M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Bailard's largest Q1 2024 buy was iShares 7-10 Year Treasury Bond ETF: 82,419 shares worth $7.8M.
- Bailard added most to iShares Russell 2000 Value ETF in Q1 2024, an estimated $69.6M increase.
- Bailard's biggest Q1 2024 reduction was SPDR Gold Trust, cutting an estimated $64.5M.
- Bailard fully exited Vanguard Small-Cap Growth ETF in Q1 2024, selling an estimated $6.53M.
- Bailard's ten largest holdings make up 28% of its $3.62B portfolio in Q1 2024.
- Bailard opened 137 new positions and closed 109 in Q1 2024.
- Bailard's portfolio value rose 7.3% quarter-over-quarter to $3.62B.
Based on Bailard's 13F filing for Q1 2024, filed 8 May 2024.